{"id":200481,"date":"2026-03-25T18:42:12","date_gmt":"2026-03-25T18:42:12","guid":{"rendered":"https:\/\/www.europesays.com\/se\/200481\/"},"modified":"2026-03-25T18:42:12","modified_gmt":"2026-03-25T18:42:12","slug":"iran-nyheter-lyfte-sentimentet-omxs30-12","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/200481\/","title":{"rendered":"IRAN-NYHETER LYFTE SENTIMENTET, OMXS30 +1,2%"},"content":{"rendered":"<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Sentimentet p\u00e5 Stockholmsb\u00f6rsen avtog n\u00e5got under onsdagseftermiddagen, och storbolagsindex st\u00e4ngde upp 1,2 procent p\u00e5 niv\u00e5n 2.943. D\u00e5 hade 26 miljarder omsatts p\u00e5 Stockholmsb\u00f6rsen i sin helhet.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">USA:s president Donald Trump har drivit p\u00e5 f\u00f6r samtal med Iran i syfte att f\u00e5 ett slut p\u00e5 striderna. Samtidigt uppgav Iran att landet inte kommer att acceptera att USA dikterar villkoren f\u00f6r ett krigsslut och att konflikten avslutas f\u00f6rst n\u00e4r Iran sj\u00e4lv anser det l\u00e4mpligt, enligt statliga Press TV rapporterar Bloomberg News.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Swedbank, Nordea och SEB handlades exklusive utdelning under dagen. F\u00f6r Swedbank r\u00f6r det sig om totalt 29:80 kronor per aktie (20:45 ordinarie och 9:35 extra) som delas ut. SEB delar ut totalt 11 kronor per aktie (8:50 ordinarie och 2:50 extra) medan Nordea avskiljer 0:96 euro per aktie, motsvarande cirka 10:38 kronor. Swedbank var ned 7,1 procent eller 23:40 kronor, Nordea sj\u00f6nk 4,5 procent eller 7,3 kronor och SEB backade 3,8 procent eller 6,8 kronor.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Bland de mest omsatta aktierna inom OMXS30 steg riskkapitalbolaget EQT med \u00f6ver 5,5 procent. P\u00e5 andra sidan spektrat \u00e5terfanns ut\u00f6ver bankaktierna Saab, som var ned 0,4 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Warner Bros h\u00e5ller p\u00e5 med en ny Sagan om Ringen-film, som Embracer \u00e4ger r\u00e4ttigheter till. Enligt Warner Bros meddelanden p\u00e5 flera sociala medier p\u00e5 tisdagskv\u00e4llen \u00e4r planen att lansera filmen 2027. Embracer avslutade upp 6,4 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">K\u00e4rnteknikf\u00f6retaget Studsvik st\u00e4rktes 14,2 procent efter att ha ing\u00e5tt avsiktsavtal med det brittiska industrif\u00f6retaget Rolls-Royce om att unders\u00f6ka ett ut\u00f6kat samarbete inom Studsviks hela tj\u00e4nsteutbud f\u00f6r att bidra till det program av sm\u00e5 modul\u00e4ra reaktorer som Rolls-Royce SMR utvecklar.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Genovis har ing\u00e5tt ett icke-exklusivt, globalt licensavtal med ett amerikanskt bioteknikf\u00f6retag f\u00f6r EndoS2-enzymteknologi inom antikroppskonjugat (ADC)-terapier. Aktien avancerade 13,7 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Xspray Pharma genomf\u00f6r en kapitalanskaffning via en f\u00f6retr\u00e4desemission. Teckningskursen sattes till 20 kronor, vilket motsvarar en rabatt p\u00e5 cirka 19 procent j\u00e4mf\u00f6rt med den teoretiska aktiekursen. Aktien rusade 9,3 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">P\u00e5 rekommendationsfronten har Danske Bank s\u00e4nkt sin rekommendation f\u00f6r Elekta till s\u00e4lj fr\u00e5n beh\u00e5ll. Aktien backade 4,3 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Guggenheim har enligt Bloomberg inlett bevakning av forskningsbolaget Vicore Pharma med en k\u00f6prekommendation och en riktkurs p\u00e5 38 kronor. Aktien steg 14 procent till 10:88 kronor per aktie.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Terranor, verksamt inom v\u00e4gunderh\u00e5ll i Norden, f\u00e5r ett drift- och underh\u00e5llskontrakt i Finland v\u00e4rt motsvarande 83 miljoner kronor. Aktien st\u00e4rktes 2,6 procent.<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">OMXS30 onsdagen den 25 mars<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\"><a class=\"text-primary-90 hover:text-primary-110 underline hover:no-underline\" rel=\"noopener noreferrer\" target=\"_blank\" href=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/03\/654923001.png\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2026\/03\/654923001.png\" alt=\"image\" class=\"rounded-2xl max-w-full\"\/><\/a><\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">K\u00e4lla: Infront<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Alice Scholander +46 8 5191 7983<\/p>\n<p class=\"font-sans text-base text-text-main dark:text-text-main-dark font-normal leading-[1.4]\">Nyhetsbyr\u00e5n Direkt<\/p>\n","protected":false},"excerpt":{"rendered":"STOCKHOLM (Nyhetsbyr\u00e5n Direkt) Sentimentet p\u00e5 Stockholmsb\u00f6rsen avtog n\u00e5got under onsdagseftermiddagen, och storbolagsindex st\u00e4ngde upp 1,2 procent p\u00e5 niv\u00e5n&hellip;\n","protected":false},"author":2,"featured_media":164641,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,70,71,10133,6995,6459,16629,5821,2200,34,2666,5796,11637,31,33,2066,32,30,16641,6996,16630],"class_list":["post-200481","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-economy","tag-ekonomi","tag-elekta","tag-embracer-group-b","tag-eqt","tag-genovis","tag-nordea-bank","tag-saab","tag-se","tag-seb","tag-seb-c","tag-studsvik","tag-svenska","tag-sverige","tag-swedbank","tag-sweden","tag-swedish","tag-terranor-group","tag-vicore-pharma-holding","tag-xspray-pharma"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/116291288846196128","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/200481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=200481"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/200481\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/164641"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=200481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=200481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=200481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}